Lin, Yong Q <br/><br/>
Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C.  [electronic resource] 

 -  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists   
 - 135-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Clinical Conference; Journal Article 
<br/><br/><label>ISSN: </label>1530-891X 
<br/><br/><label>Standard No.: </label>10.4158/EP.11.2.135  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Antithyroid Agents--therapeutic use<br/>Antiviral Agents--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Middle Aged<br/>Patient Compliance<br/>Polyethylene Glycols<br/>Propranolol--therapeutic use<br/>Propylthiouracil--therapeutic use<br/>Recombinant Proteins<br/>Retreatment<br/>Ribavirin--adverse effects<br/>Severity of Illness Index<br/>Thyrotoxicosis--chemically induced